GovernmentGovernment health research
- Source type
- Government
- Access type
- Official
- Publisher
- Substance Abuse and Mental Health Services Administration
- Added
- 2026-06-19
Trust profile
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
Regulatory statussignal6 references
GLP-1s, Dopamine, and Addiction: The Substance Use Signal
Roles: Regulatory status
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
No structured study record is currently attached to this source.
Related sources
Trial registryClinical trial registry
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
GLP-1R Agonist Treatment for Opioid Use Disorder
Trial registry testing whether semaglutide can reduce illicit opioid use in adults in outpatient OUD treatment.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Semaglutide for Alcohol Use Disorder
Trial registry for early-phase semaglutide AUD trial.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 4 connections
Trial registryClinical trial registry
Semaglutide Therapy for Alcohol Reduction
Trial registry for semaglutide therapy for alcohol reduction.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
GovernmentGovernment health research
Effects of semaglutide and tirzepatide on stimulant and opioid use disorder outcomes in real-world populations
NIDA Clinical Trials Network study page on semaglutide/tirzepatide and SUD outcomes.
- Trust score
- 91
- Publisher
- National Institute on Drug Abuse
- Access
- Official
- Usage
- 2 connections
Topic tags
substance-use-disorderalcohol-use-disorderopioid-use-disorderbehavioral-health